S&P 500: Dovish repricing lifts breadth – Deutsche Bank
Deutsche Bank strategists Jim Reid and colleagues note that a softer US jobs report reduced expectations for further Federal Reserve tightening in 2026, with just 30 bps of hikes priced by December. US Treasuries rallied at the front end, while the S&P 500 was held back by semiconductor weakness even as the equal-weighted S&P 500 hit fresh highs. The team highlights broad equity strength underpinned by lower Oil prices and dovish rate repricing.
Broad US equities gain as chips lag
"Ahead of that, markets put in another strong performance yesterday, as an underwhelming US jobs report led to mounting hopes that the Fed wouldn’t hike rates this year. Indeed, the newsflow was pretty dovish in general, as we saw Brent crude trade within touching distance of $70/bbl for the first time since February, though it ultimately settled +0.32% higher on the day at $71.80/bbl."
"But because payrolls grew by less than the +113k reading expected, the print also helped to push back against the prospect of an imminent rate hike. Indeed, the details included downward revisions to the April and May prints of -74k in total, which took the 3-month average for payrolls down to +111k, so relative to expectations it generally underwhelmed."
"This backdrop of lower oil prices and a dovish repricing was generally a very strong one for equities. That was particularly clear in Europe given its exposure to the energy shock, and the STOXX 600 (+1.41%) hit a new record high, as did the DAX (+2.16%). In the US, equities also did very well for the most part, though the S&P 500 index rose by a mere hundredth of a point to 7483.24 (+0.0001%) as its advance was curtailed by another slump in chip stocks."
"Indeed, the Philly semiconductor index was down -5.44% yesterday, building on its -6.27% decline on Wednesday, with all 30 companies in the index losing ground. So given that semiconductor stocks make up around a sixth of the S&P 500, it was tough for the index to gain much traction, even though 70% of its constituents still advanced on the day."
(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SUI SuperTrend Flips to Buy — Macro Shift From Bearish to Bullish Begins

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

STONK hits new highs after erasing 27% crash

25 Days, Four Launches in Sight! Rocket Lab (RKLB.US) Accelerates Rocket Launches to Advance Its Ambitious "Space AI Infrastructure" Goals
After another successful mission, Rocket Lab's 97th Electron rocket is now positioned at the launch pad. This flight will be Rocket Lab's fourth launch in 25 days and its 18th launch in 2026.
